Unusual mutations in Btk: An insertion, a duplication, an inversion, and four large deletions

Clinical Immunology

Volumn 90, Issue 1, 1999, Pages 28-37

  Rohrer, Jurg ^a   Minegishi, Yoshiyuki ^a   Richter, Darko ^b   Eguiguren, Jose ^c   Conley, Mary Ellen ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b KBC Zagreb   (Croatia)

^c HOSPITAL METROPOLITANO   (Ecuador)

Author keywords

Agammaglobulinemia; B cells; Btk; Immunodeficiency; Mutation

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; EXON; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RESTRICTION SITE; RETROPOSON; SEQUENCE ANALYSIS; X CHROMOSOME; X LINKED AGAMMAGLOBULINEMIA;

EID: 0032911903     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4629     Document Type: Article

References (39)

1. Lederman H. M., Winkelstein J. A. X-linked agammaglobulinemia: An analysis of 96 patients. Medicine. 64:1985;145-156.
2. Conley M. E., Parolini O., Rohrer J., Campana D. X-linked agammaglobulinemia: New approaches to old questions based on the identification of the defective gene. Immunol. Rev. 138:1994;5-21.
3. Tsukada S., Saffran D. C., Rawlings D. J., Parolini O., Allen R. C., Klisak I., Sparkes R. S., Kubagawa H., Mohandas T., Quan S., Belmont J. W., Coolper M. D., Conley M. E., Witte O. N. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 72:1993;279-290.
4. Vetrie D., Vorechovsky I., Sideras P., Holland J., Davies A., Flinter F., Hammarstrom L., Kinnon C., Levinsky R., Bobrow M., Smith C. I. E., Bentley D. R. The gene involved in X-linked agammaglobulinemia is a member of thesrc. Nature. 361:1993;226-233.
5. Siliciano J. D., Morrow T. A., Desiderio S. V. itk. Proc. Natl. Acad. Sci. USA. 89:1992;11194-11198.
6. Mano H., Mano K., Tang B., Koehler M., Yi T., Gilbert D. J., Jenkins N. A., Copeland N. G., Ihle J. N. Expression of a novel form ofTecKit. Oncogene. 8:1993;417-424.
7. Tamagnone L., Lahtinen I., Mustonen T., Virtaneva K., Francis F., Muscatelli F., Alitalo R., Smith C. I. E., Larsson C., Alitalo K. BMX, a novel nonreceptor tyrosine kinase gene of theBTK/ITK/TEC/TXK. Oncogene. 9:1994;3683-3688.
8. Desiderio S. Role of Btk in B cell development and signaling. Curr. Opin. Immunol. 9:1997;534-540.
9. Rohrer J., Parolini O., Belmont J. W., Conley M. E. The genomic structure of humanBTK. Immunogenetics. 40:1994;319-324.
10. Hagemann T. L., Chen Y., Rosen F. S., Kwan S.-P. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hum. Mol. Genet. 3:1994;1743-1749.
11. Ohta Y., Haire R. N., Litman R. T., Fu S. M., Nelson R. P., Kratz J., Kornfeld S. J., De La Morena M., Good R. A., Litman G. W. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. Proc. Natl. Acad. Sci. USA. 91:1994;9062-9066.
12. Sideras P., Muller S., Shiels H., Jin H., Khan W. N., Nilsson L., Parkinson E., Thomas J. D., Branden L., Larsson I. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J. Immunol. 153:1994;5607-5617.
13. Oeltjen J. C., Malley T. M., Muzny D. M., Miller W., Gibbs R. A., Belmont J. W. Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res. 7:1997;315-329.
14. Vihinen M., Brandau O., Branden L. J., Kwan S. P., Lappalainen I., Lester T., Noordzij J. G., Ochs H. D., Ollila J., Pienaar S. M., Riikonen P., Saha B. K., Smith C. I. E. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 26:1998;242-247.
15. Conley M. E., Mathias D., Treadaway J., Minegishi Y., Rohrer J. Mutations in Btk in patients with presumed X-linked agammaglobulinemia. Am. J. Hum. Genet. 62:1998;1034-1043.
16. Jin H., Webster A. D. B., Vihinen M., Sideras P., Vorechovsky I., Hammarstrom L., Bernatowska-Matuszkiewicz E., Smith C. I. E., Bobrow M., Vetrie D. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinemia (XLA). Hum. Mol. Genet. 4:1995;693-700.
17. Vorechovsky I., Vihinen M., de Saint Basile G., Honsová S., Hammarström L., Müller S., Nilsson L., Fischer A., Smith C. I. E. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Hum. Mol. Genet. 4:1995;51-58.
18. Hashimoto S., Tsukada S., Matsushita M., Miyawaki T., Niida Y., Yachie A., Kobayashi S., Iwata T., Hayakawa H., Matsuoka H., Tsuge I., Yamadori T., Kunikata T., Arai S., Yoshizaki K., Taniguchi N., Kishimoto T. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: A nationwide study of Btk deficiency in Japan. Blood. 88:1995;561-573.
19. Kobayashi S., Iwata T., Saito M., Iwasaki R., Matsumoto H., Naritaka S., Kono Y., Hayashi Y. Mutations of theBtk. Hum. Genet. 97:1996;424-430.
20. de Weers M., Dingjan G. M., Brouns G. S., Kraakman M. E. M., Mensink R. G. J., Lovering R. C., Schuurman R. K. B., Borst J., Hendriks R. W. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinemia patients. Clin. Exp. Immunol. 107:1997;235-240.
21. Conley M. E., Fitch-Hilgenberg M. E., Cleveland J. L., Parolini O., Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum. Mol. Genet. 3:1994;1751-1175.
22. Conley M. E., Puck J. M. Carrier detection in typical and atypical X-linked agammaglobulinemia. J. Pediatr. 112:1988;688-694.
23. Ono M., Kawakami M., Takezawa T. A novel human nonviral retroposon derived from an endogenous retrovirus. Nucleic Acids Res. 15:1987;8725-8737.
24. Amariglio N., Rechavi G. Insertional mutagenesis by transposable elements in the mammalian genome. Environ. Mol. Mutagen. 21:1993;212-218.
25. Deininger P. L., Jolly D. J., Rubin C. M., Friedmann T., Schmid C. W. Base sequence studies of 300 nucleotide renatured repeated human DNA clones. Mol. Biol. 151:1981;17-33.
26. Zhu Q., Zhang M., Rawlings D. J., Vihinen M., Hagemann T., Saffran D. C., Kwan S.-P., Nilsson L., Smith C. I. E., Witte O. N., Chen S.-H., Ochs H. D. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J. Exp. Med. 180:1994;461-470.
27. Lakich D., Kazazian H. H., Antonarakis S. E., Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nature Genet. 5:1993;236-241.
28. Lagerstedt K., Karsten S. L., Carlberg B.-M., Kleijer W. J., Tonnesen T., Pettersson U., Bondeson M.-L. Double-strand breaks may initiate the inversion mutation causing the Hunter syndrome. Hum. Mol. Genet. 6:1997;627-633.
29. Karathanasis S. K., Ferris E., Haddad I. A. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc. Natl. Acad. Sci. USA. 84:1987;7198-7202.
30. Hu X., Worton R. G. Partial gene duplication as a cause of human disease. Hum. Mutat. 1:1992;3-12.
31. Reiter L. T., Murakami T., Koeuth T., Gibbs R. A., Lupski J. R. The humanCOX10. Hum. Mol. Genet. 6:1997;1595-1603.
32. van Essen A. J., Kneppers A. L. J., van der Hout A. H., Scheffer H., Ginjaar I. B., ten Kate L. P., van Ommen G.-J. B., Buys C. H. C. M., Bakker E. The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: An updated protocol. J. Med. Genet. 34:1997;805-812.
33. Rudiger N. S., Gregersen N., Kielland-Brandt M. C. One short well conserved region ofAluchi. Nucleic Acids Res. 23:1995;256-260.
34. Vanin E. F., Henthorn P. S., Kioussis D., Grosveld F., Smithies O. Unexpected relationships between four large deletions in the human beta-globin gene cluster. Cell. 35:1983;701-709.
35. Butti M. G., Bongarzone I., Ferraresi G., Mondellini P., Borrelo M. G., Pierotti M. A. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas. Genomics. 28:1995;15-24.
36. Lohmann D. R., Brandt B., Hopping W., Passarge E., Horsthemke B. The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am. J. Hum. Genet. 58:1996;940-949.
37. Upadhyaya M., Shen M., Cherryson A., Farnham J., Maynard J., Huson S. M., Harper P. S. Analysis of mutations at the neurofibromatosis 1 (NF1) locus. Hum. Mol. Genet. 1:1992;735-740.
38. Richards F. M., Crossey P. A., Phipps M. E., Foster K., Latif F., Evans G., Sampson J., Lerman M. I., Zbar B., Affara N. A., Ferguson-Smith M., Maher E. R. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum. Mol. Genet. 3:1994;595-598.
39. Gilad S., Khosravi R., Shkedy D., Uziel T., Ziv Y., Savitsky K., Rotman G., Smith S., Chessa L., Jorgensen T. J., Harnik R., Frydman M., Sanal O., Portnoi S., Goldwicz Z., Jaspers N. G. J., Gatti R. A., Lenoir G., Lavin M. F., Tatsumi K., Wegner R. D., Shiloh Y., Bar-Shira A. Predominance of null mutations in ataxia-telangiectasia. Hum. Mol. Genet. 5:1996;433-439.